Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2018 Jul 1;136(7):779-785.
doi: 10.1001/jamaophthalmol.2018.1746.

Association Between 24-Hour Intraocular Pressure Monitored With Contact Lens Sensor and Visual Field Progression in Older Adults With Glaucoma

Affiliations
Multicenter Study

Association Between 24-Hour Intraocular Pressure Monitored With Contact Lens Sensor and Visual Field Progression in Older Adults With Glaucoma

Carlos Gustavo De Moraes et al. JAMA Ophthalmol. .

Abstract

Importance: Twenty-four-hour intraocular pressure (IOP) patterns may provide more information regarding rates of visual field progression than office-hour measurements. However, little is known about the added value of 24-hour monitoring when stratifying glaucoma risk based on rates of progression.

Objective: To test the hypothesis that 24-hour IOP-related patterns recorded with a contact lens sensor (CLS) correlate with prior rates of visual field progression.

Design, setting, and participants: A multicenter, retrospective cohort study was conducted at 50 ophthalmology care centers in 13 countries. Participants included 445 patients (445 eyes) with treated, manifest open-angle glaucoma. The study was conducted from November 8, 1999, to September 17, 2016.

Interventions: Twenty-four-hour recordings of IOP-related patterns were prospectively collected with a CLS system. Retrospective visual field data of patients who underwent at least 3 prior reliable visual field tests were examined.

Main outcomes and measures: Association between CLS variables and rates of visual field mean deviation (MD) change.

Results: Of the 445 patients included, 238 (53.5%) were women and 394 (88.5%) were white. The mean (SD) age and MD values at the time of CLS recording were 68.9 (11.2) years and -9.0 (7.0) dB. The mean rate of MD change was -0.46 (0.5) dB/y in 5.2 (3) years of follow-up. After adjusting for baseline MD severity, age, and treatment, the following CLS variables were associated with fast visual field progression: mean peak ratio while awake (β = -0.021; 95% CI, -0.04 to -0.003), number of long peaks during sleep (β = 0.036; 95% CI, 0.005 to 0.067), night bursts ocular pulse frequency SD (β = 0.027; 95% CI, 0.004 to 0.051), and night bursts ocular pulse amplitude SD (β = 19.739; 95% CI, 1.333 to 38.145). Regression models including CLS variables had better fit than Goldmann IOP when testing the association with rates of progression.

Conclusions and relevance: Results of this study indicate that 24-hour CLS recordings may be associated with prior rates of visual field progression of glaucoma. This association appears to be better than Goldmann mean IOP measured multiple times during office hours. Therefore, the CLS may be useful to assess the risk of future functional loss, even in situations when insufficient historical visual field information is available.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr De Moraes has received research support from Heidelberg Engineering GmbH, Carl Zeiss Meditec Inc, and Topcon Inc. Dr Mansouri has served as a consultant for Sensimed AG. Dr Liebmann has served as a consultant for Sensimed AG, Arie Pharmaceuticals Inc, Alcon Laboratories Inc, Allergan Inc, Bausch & Lomb Inc, Carl Zeiss Meditec Inc, Forsight Visio5, Heidelberg Engineering GmbH, Inotek Pharmaceuticals Inc, Quark Pharmaceuticals Inc, Reichert Inc, and Sustained Nanosystems; has received research support from Heidelberg Engineering GmbH; and is equity owner of Forsight Visio5 and Sustained Nanosystems. Dr Ritch has served as a consultant for Sensimed AG, Aeon Astron Europe, Gerson Lehrman Group, Diopsys Inc, GLIA, and Guardion Health Sciences; is a member of the advisory board for Intelon Optics and iSonic Medical; has received speaker fees from Santen Pharmaceutical; and has received royalties from Ocular Instruments. No other disclosures were reported.

Figures

Figure.
Figure.. Baseline Mean Deviation (MD) and MD Slopes
A, Histogram showing the distribution of mean (SD) of the mean deviation (MD) values (dB) closest to the date of contact lens sensor recording (mean, −9.0 [7.0] dB). B, Histogram showing the distribution of MD slopes (dB) during the 5.2 (3.0) years of follow-up (mean, −0.46 [0.5] dB/y).

Similar articles

Cited by

References

    1. Gordon MO, Beiser JA, Brandt JD, et al. . The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):714-720. - PubMed
    1. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E; Early Manifest Glaucoma Trial Group . Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma trial. Arch Ophthalmol. 2003;121(1):48-56. - PubMed
    1. The AGIS Investigators The Advanced Glaucoma Intervention Study (AGIS)—7: the relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130(4):429-440. - PubMed
    1. Collaborative Normal-Tension Glaucoma Study Group The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol. 1998;126(4):498-505. - PubMed
    1. Musch DC, Gillespie BW, Niziol LM, Lichter PR, Varma R; CIGTS Study Group . Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2011;118(9):1766-1773. - PMC - PubMed

Publication types